(NASDAQ: SLGL) Sol Gel Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.52%.
Sol Gel Technologies's earnings in 2026 is -$16,337,000.On average, 5 Wall Street analysts forecast SLGL's earnings for 2026 to be -$27,934,742, with the lowest SLGL earnings forecast at -$37,796,354, and the highest SLGL earnings forecast at -$17,016,610. On average, 5 Wall Street analysts forecast SLGL's earnings for 2027 to be -$33,645,251, with the lowest SLGL earnings forecast at -$48,769,489, and the highest SLGL earnings forecast at -$17,016,610.
In 2028, SLGL is forecast to generate -$11,688,176 in earnings, with the lowest earnings forecast at -$11,229,817 and the highest earnings forecast at -$12,031,946.